Design of Polyelectrolyte Multilayers to Promote Immunological Tolerance

Area of Science:

• Immunology
• Nanotechnology
• Biomaterials

Background:

• Excessive toll-like receptor (TLR) signaling drives autoimmune diseases like multiple sclerosis (MS).
• Current treatments often use synthetic carriers that can cause inflammation, potentially worsening autoimmune conditions.

Purpose of the Study:

• To investigate if co-delivering myelin peptide and a TLR9 regulatory ligand (GpG oligonucleotide) via immune polyelectrolyte multilayers (iPEMs) can reduce inflammation in MS.
• To develop a carrier-free platform for modulating immune responses and promoting tolerance in autoimmunity.

Main Methods:

• Assembled myelin peptide and GpG oligonucleotide into nanostructured iPEMs.
• Assessed the effect of iPEMs on TLR9 signaling, dendritic cell activation, and T cell differentiation in vitro.
• Evaluated the therapeutic efficacy of iPEMs in a mouse model of MS and in human MS patient samples.

Main Results:

• iPEMs effectively restrained TLR9 signaling and reduced dendritic cell activation.
• Myelin-specific T cells were polarized towards a tolerogenic phenotype.
• Treatment with iPEMs ameliorated disease in a mouse model of MS and promoted immune tolerance in human MS patient cells.

Conclusions:

• Carrier-free iPEMs represent a novel platform for modulating TLR function and reducing inflammation.
• This approach holds potential for treating autoimmune diseases by promoting immune tolerance.
• iPEMs offer a tunable, biomimetic strategy for autoimmune disease therapy.